DEF 14AThe Ballot
Enliven Therapeutics, Inc. files DEF 14A
Filed Apr 26, 2024 · 2y ago · Accession 0001193125-24-117969
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- DEF 14A
- Filing date
- Apr 26, 2024
- Report date
- Jun 18, 2024
- Document
- d746513ddef14a.htm
- Size
- 1.1 MB